Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 DDX10 CCT6A SMC3 CCT6B KIF14 DHX29 SNRNP200 ATP5F1C	1.04e-07	441	142	16	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 DDX10 CCT6A SMC3 CCT6B KIF14 MYO15A DHX29 SNRNP200 TOP2B ATP5F1C	3.80e-07	614	142	18	GO:0140657
GeneOntologyMolecularFunction	helicase activity	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.76e-05	158	142	8	GO:0004386
GeneOntologyMolecularFunction	cyclase activity	NPR1 NPR2 ADCY1 GUCY1B2	2.33e-05	24	142	4	GO:0009975
GeneOntologyMolecularFunction	phosphorus-oxygen lyase activity	NPR1 NPR2 ADCY1 GUCY1B2	2.76e-05	25	142	4	GO:0016849
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 CCT6A SMC3 CCT6B KIF14 DHX29 SNRNP200 ATP5F1C	3.72e-05	775	142	17	GO:0017111
GeneOntologyMolecularFunction	guanylate cyclase activity	NPR1 NPR2 GUCY1B2	4.07e-05	10	142	3	GO:0004383
GeneOntologyMolecularFunction	D-ribulose-phosphate 3-epimerase activity	RPEL1 RPE	5.02e-05	2	142	2	GO:0004750
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 CCT6A SMC3 CCT6B KIF14 DHX29 SNRNP200 ATP5F1C	9.87e-05	839	142	17	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 CCT6A SMC3 CCT6B KIF14 DHX29 SNRNP200 ATP5F1C	1.00e-04	840	142	17	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 CCT6A SMC3 CCT6B KIF14 DHX29 SNRNP200 ATP5F1C	1.00e-04	840	142	17	GO:0016818
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD3 CHD4 BTAF1 SRCAP	1.35e-04	37	142	4	GO:0140658
GeneOntologyMolecularFunction	natriuretic peptide receptor activity	NPR1 NPR2	1.50e-04	3	142	2	GO:0016941
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	CCZ1B ABR TRIO RAPGEF4 ARHGEF11 PLEKHG5 CCZ1 FGD5	2.52e-04	231	142	8	GO:0005085
GeneOntologyMolecularFunction	adenylate cyclase activity	NPR1 NPR2 ADCY1	2.66e-04	18	142	3	GO:0004016
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	GIPC1 CCZ1B ABR TRIO RAPGEF4 ARHGEF11 PLEKHG5 ARFGAP2 CCZ1 ARHGAP44 FGD5 RIMS1	2.77e-04	507	142	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	GIPC1 CCZ1B ABR TRIO RAPGEF4 ARHGEF11 PLEKHG5 ARFGAP2 CCZ1 ARHGAP44 FGD5 RIMS1	2.77e-04	507	142	12	GO:0030695
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase inhibitor activity	WASHC1 PIK3IP1	1.37e-03	8	142	2	GO:0141039
GeneOntologyMolecularFunction	cytoskeletal protein binding	GIPC1 NEBL STUB1 SYNM EML4 SPTAN1 CAPN2 WASHC1 PSMD10 SNX6 SMC3 USH1G KIF14 KCNQ2 LMOD1 MICAL3 MYO15A	2.09e-03	1099	142	17	GO:0008092
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	CHD3 CHD4 BTAF1 SRCAP TOP2B	2.15e-03	127	142	5	GO:0008094
GeneOntologyCellularComponent	dystrophin-associated glycoprotein complex	SGCD DTNA SGCZ	3.42e-04	20	145	3	GO:0016010
GeneOntologyCellularComponent	sarcomere	NEBL STUB1 SYNM KLHL40 SPTAN1 SLC2A1 LMOD1 AK1	3.55e-04	249	145	8	GO:0030017
GeneOntologyCellularComponent	Mon1-Ccz1 complex	CCZ1B CCZ1	4.71e-04	5	145	2	GO:0035658
GeneOntologyCellularComponent	myofibril	NEBL STUB1 SYNM KLHL40 SPTAN1 SLC2A1 LMOD1 AK1	6.51e-04	273	145	8	GO:0030016
GeneOntologyCellularComponent	glycoprotein complex	SGCD DTNA SGCZ	6.72e-04	25	145	3	GO:0090665
GeneOntologyCellularComponent	sarcoglycan complex	SGCD SGCZ	7.04e-04	6	145	2	GO:0016012
MousePheno	abnormal head shape	NPR2 SPTAN1 CILK1 FAT1 TMEM209 KIF14 TOP2B PCNT	4.38e-06	115	114	8	MP:0011495
Domain	Helicase_C	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.67e-06	107	143	8	PF00271
Domain	HELICc	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.67e-06	107	143	8	SM00490
Domain	Helicase_C	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.79e-06	108	143	8	IPR001650
Domain	HELICASE_CTER	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.92e-06	109	143	8	PS51194
Domain	HELICASE_ATP_BIND_1	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.92e-06	109	143	8	PS51192
Domain	DEXDc	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	1.92e-06	109	143	8	SM00487
Domain	Helicase_ATP-bd	DHX38 CHD3 CHD4 BTAF1 SRCAP DDX10 DHX29 SNRNP200	2.06e-06	110	143	8	IPR014001
Domain	Guanylate_cyc	NPR1 NPR2 ADCY1 GUCY1B2	1.17e-05	19	143	4	PF00211
Domain	GUANYLATE_CYCLASE_2	NPR1 NPR2 ADCY1 GUCY1B2	1.17e-05	19	143	4	PS50125
Domain	A/G_cyclase	NPR1 NPR2 ADCY1 GUCY1B2	1.17e-05	19	143	4	IPR001054
Domain	GUANYLATE_CYCLASE_1	NPR1 NPR2 ADCY1 GUCY1B2	1.17e-05	19	143	4	PS00452
Domain	CYCc	NPR1 NPR2 ADCY1 GUCY1B2	1.17e-05	19	143	4	SM00044
Domain	Ribul_P_3_epim	RPEL1 RPE	5.82e-05	2	143	2	PF00834
Domain	Chap_CCT_zeta	CCT6A CCT6B	5.82e-05	2	143	2	IPR012722
Domain	DUF1712	CCZ1B CCZ1	5.82e-05	2	143	2	PF08217
Domain	RIBUL_P_3_EPIMER_1	RPEL1 RPE	5.82e-05	2	143	2	PS01085
Domain	Ribul_P_3_epim	RPEL1 RPE	5.82e-05	2	143	2	IPR026019
Domain	DUF1712_fun	CCZ1B CCZ1	5.82e-05	2	143	2	IPR013176
Domain	Ribul_P_3_epim-like	RPEL1 RPE	5.82e-05	2	143	2	IPR000056
Domain	SNF2_N	CHD3 CHD4 BTAF1 SRCAP	1.00e-04	32	143	4	IPR000330
Domain	SNF2_N	CHD3 CHD4 BTAF1 SRCAP	1.00e-04	32	143	4	PF00176
Domain	DNA/RNA_helicase_DEAH_CS	DHX38 CHD3 CHD4 DHX29	1.43e-04	35	143	4	IPR002464
Domain	MFS_sugar_transport-like	SLC2A1 SLC22A6 SV2B SLC2A12	1.60e-04	36	143	4	IPR005828
Domain	Sugar_tr	SLC2A1 SLC22A6 SV2B SLC2A12	1.60e-04	36	143	4	PF00083
Domain	RhoGEF	ABR TRIO ARHGEF11 PLEKHG5 FGD5	1.74e-04	68	143	5	SM00325
Domain	CHD_N	CHD3 CHD4	1.74e-04	3	143	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	1.74e-04	3	143	2	IPR012957
Domain	RibuloseP-bd_barrel	RPEL1 RPE	1.74e-04	3	143	2	IPR011060
Domain	ANF_RECEPTORS	NPR1 NPR2	1.74e-04	3	143	2	PS00458
Domain	CHDCT2	CHD3 CHD4	1.74e-04	3	143	2	PF08074
Domain	CHDNT	CHD3 CHD4	1.74e-04	3	143	2	PF08073
Domain	DUF1086	CHD3 CHD4	1.74e-04	3	143	2	IPR009462
Domain	DUF1087	CHD3 CHD4	1.74e-04	3	143	2	IPR009463
Domain	ANPR/GUC	NPR1 NPR2	1.74e-04	3	143	2	IPR001170
Domain	DUF1087	CHD3 CHD4	1.74e-04	3	143	2	PF06465
Domain	DUF1086	CHD3 CHD4	1.74e-04	3	143	2	PF06461
Domain	DUF1087	CHD3 CHD4	1.74e-04	3	143	2	SM01147
Domain	DUF1086	CHD3 CHD4	1.74e-04	3	143	2	SM01146
Domain	DEAH_ATP_HELICASE	DHX38 CHD3 CHD4 DHX29	1.99e-04	38	143	4	PS00690
Domain	RhoGEF	ABR TRIO ARHGEF11 PLEKHG5 FGD5	1.99e-04	70	143	5	PF00621
Domain	DH_2	ABR TRIO ARHGEF11 PLEKHG5 FGD5	1.99e-04	70	143	5	PS50010
Domain	-	ABR TRIO ARHGEF11 PLEKHG5 FGD5	2.13e-04	71	143	5	1.20.900.10
Domain	DH-domain	ABR TRIO ARHGEF11 PLEKHG5 FGD5	2.13e-04	71	143	5	IPR000219
Domain	A/G_cyclase_CS	NPR1 NPR2 ADCY1	2.76e-04	17	143	3	IPR018297
Domain	-	NPR1 NPR2 ADCY1	3.30e-04	18	143	3	3.30.70.1230
Domain	Nucleotide_cyclase	NPR1 NPR2 ADCY1	3.30e-04	18	143	3	IPR029787
Domain	Sarcoglycan_1	SGCD SGCZ	3.46e-04	4	143	2	PF04790
Domain	Sarcoglycan	SGCD SGCZ	3.46e-04	4	143	2	IPR006875
Domain	EF_Hand_1_Ca_BS	ANKRD42 SPTAN1 CAPN2 EFHB DNAH7 CAPN11 FKBP14	4.04e-04	175	143	7	IPR018247
Domain	-	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 SMC3 AK1 MYO15A DHX29 SNRNP200	6.07e-04	746	143	15	3.40.50.300
Domain	P-loop_NTPase	ABCA12 DHX38 ABCF2 CHD3 CHD4 BTAF1 SRCAP DNAH7 ATL1 DDX10 SMC3 KIF14 AK1 MYO15A DHX29 SNRNP200	7.89e-04	848	143	16	IPR027417
Domain	WH2	WASHC1 LMOD1 WASH2P	7.91e-04	24	143	3	PS51082
Domain	EF-hand_1	LPCAT1 SPTAN1 CAPN2 EFHB CAPN11 FKBP14	1.13e-03	152	143	6	PF00036
Domain	EFh	LPCAT1 SPTAN1 CAPN2 EFHB CAPN11 FKBP14	1.37e-03	158	143	6	SM00054
Domain	DH_1	ABR TRIO ARHGEF11 PLEKHG5	1.38e-03	63	143	4	PS00741
Domain	Spectrin_repeat	TRIO SPTAN1 EVPL	1.39e-03	29	143	3	IPR002017
Domain	TPR_REGION	STUB1 FIS1 ODAD4 TTC1 CLUH CFAP46	1.71e-03	165	143	6	PS50293
Domain	TPR	STUB1 FIS1 ODAD4 TTC1 CLUH CFAP46	1.71e-03	165	143	6	PS50005
Domain	Sugar_transporter_CS	SLC2A1 SV2B SLC2A12	1.85e-03	32	143	3	IPR005829
Domain	SPEC	TRIO SPTAN1 EVPL	1.85e-03	32	143	3	SM00150
Domain	Spectrin/alpha-actinin	TRIO SPTAN1 EVPL	1.85e-03	32	143	3	IPR018159
Domain	Chaprnin_Cpn60	CCT6A CCT6B	2.02e-03	9	143	2	IPR001844
Domain	Chaperonin_TCP-1_CS	CCT6A CCT6B	2.02e-03	9	143	2	IPR002194
Domain	EF_hand_dom	LPCAT1 SPTAN1 CAPN2 EFHB DNAH7 CAPN11 FKBP14	2.09e-03	232	143	7	IPR002048
Domain	EF-hand_8	LPCAT1 CAPN2 CAPN11	2.21e-03	34	143	3	PF13833
Domain	DEAD/DEAH_box_helicase_dom	DHX38 DDX10 DHX29 SNRNP200	2.38e-03	73	143	4	IPR011545
Domain	DEAD	DHX38 DDX10 DHX29 SNRNP200	2.38e-03	73	143	4	PF00270
Domain	TCP1_1	CCT6A CCT6B	2.52e-03	10	143	2	PS00750
Domain	TCP1_2	CCT6A CCT6B	2.52e-03	10	143	2	PS00751
Domain	TCP1_3	CCT6A CCT6B	2.52e-03	10	143	2	PS00995
Domain	Chaperone_TCP-1	CCT6A CCT6B	2.52e-03	10	143	2	IPR017998
Domain	-	CCT6A CCT6B	3.06e-03	11	143	2	3.30.260.10
Domain	TCP-1-like_intermed	CCT6A CCT6B	3.06e-03	11	143	2	IPR027410
Domain	GDS_CDC24_CS	ABR TRIO ARHGEF11	3.28e-03	39	143	3	IPR001331
Domain	calpain_III	CAPN2 CAPN11	3.65e-03	12	143	2	SM00720
Domain	C2_III	CAPN2 CAPN11	3.65e-03	12	143	2	IPR033883
Domain	Calpain_III	CAPN2 CAPN11	3.65e-03	12	143	2	IPR022683
Domain	-	LPCAT1 DTNA SPTAN1 CAPN2 EFHB CAPN11 FKBP14	4.01e-03	261	143	7	1.10.238.10
Domain	Calpain_III	CAPN2 CAPN11	4.30e-03	13	143	2	PF01067
Domain	Calpain_domain_III	CAPN2 CAPN11	4.30e-03	13	143	2	IPR022682
Domain	EF_HAND_1	LPCAT1 SPTAN1 CAPN2 EFHB CAPN11 FKBP14	4.89e-03	204	143	6	PS00018
Domain	GROEL-like_equatorial	CCT6A CCT6B	4.99e-03	14	143	2	IPR027413
Domain	Sugar/inositol_transpt	SLC2A1 SLC2A12	4.99e-03	14	143	2	IPR003663
Domain	Calpain_cysteine_protease	CAPN2 CAPN11	4.99e-03	14	143	2	IPR022684
Domain	-	CCT6A CCT6B	4.99e-03	14	143	2	1.10.560.10
Domain	-	STUB1 FIS1 ODAD4 TTC1 CLUH CFAP46	5.25e-03	207	143	6	1.25.40.10
Domain	Znf_FYVE_PHD	KMT2B CHD3 CHD4 FGD5 RIMS1	5.50e-03	147	143	5	IPR011011
Domain	-	ABR RIMS1 BAIAP3 SNRNP200 CCDC33	5.65e-03	148	143	5	2.60.40.150
Domain	Peptidase_C2	CAPN2 CAPN11	5.73e-03	15	143	2	PF00648
Domain	GroEL-like_apical_dom	CCT6A CCT6B	5.73e-03	15	143	2	IPR027409
Domain	Cpn60/TCP-1	CCT6A CCT6B	5.73e-03	15	143	2	IPR002423
Domain	CysPc	CAPN2 CAPN11	5.73e-03	15	143	2	SM00230
Domain	Peptidase_C2_calpain_cat	CAPN2 CAPN11	5.73e-03	15	143	2	IPR001300
Domain	Cpn60_TCP1	CCT6A CCT6B	5.73e-03	15	143	2	PF00118
Domain	-	CCT6A CCT6B	5.73e-03	15	143	2	3.50.7.10
Domain	CALPAIN_CAT	CAPN2 CAPN11	5.73e-03	15	143	2	PS50203
Domain	FKBP_PPIASE	FKBP2 FKBP14	6.51e-03	16	143	2	PS50059
Domain	FKBP_C	FKBP2 FKBP14	6.51e-03	16	143	2	PF00254
Domain	EF-hand-dom_pair	LPCAT1 DTNA SPTAN1 CAPN2 EFHB CAPN11 FKBP14	6.68e-03	287	143	7	IPR011992
Domain	DUF1605	DHX38 DHX29	7.34e-03	17	143	2	IPR011709
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL21 CASP14 EML4 ACLY SPTAN1 CAPN2 DHX38 ABCF2 GPATCH4 CHD4 IDH3B SRCAP IFI16 SLC2A1 LUZP1 DDX10 PLEK2 CCT6A SMC3 CCT6B SCFD1 DHX29 SNRNP200 TOP2B ATP5F1C	5.36e-10	1353	147	25	29467282
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RPL21 STUB1 TRIO CILK1 TTC1 ARHGEF11 DNAH7 LUZP1 PHKB CCT6A ARFGAP2 SYNJ2 AASS WDCP TMEM209 CCT6B KIF14 MICAL3 PRRC2B PCNT	6.29e-10	853	147	20	28718761
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL21 TRIO ACLY SPTAN1 FN3KRP DHX38 FASTKD5 ABCF2 GPATCH4 CHD4 IDH3B SLC2A1 DDX10 CCT6A GUCY1B2 SMC3 KIF14 FGD5 SCFD1 DHX29 SNRNP200 CLUH TOP2B ATP5F1C	7.53e-09	1425	147	24	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL21 TRIO ACLY SPTAN1 RAPGEF4 CHD3 IDH3B ARHGEF11 PLEKHG5 SLC2A1 LUZP1 PHKB CCT6A SLC44A1 SV2B ARHGAP44 KCNQ2 MICAL3 RIMS1 MAP2K1 DHX29 SNRNP200 PRRC2B ATP5F1C	8.16e-09	1431	147	24	37142655
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PPAN KMT2B STUB1 EML4 ACLY SPTAN1 CHD3 CHD4 BTAF1 IFI16 MICAL3 RIMS1 SCFD1 DHX29 SNRNP200 CLUH TOP2B	3.44e-08	774	147	17	15302935
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL21 SLC25A18 PPAN DTNA SPTAN1 KHDRBS2 ABCF2 CHD3 CHD4 SRCAP LUZP1 CAPN11 PLEK2 PSME3IP1 CCT6A TNRC18 AK1 RIMS1 TOP2B PRRC2B CFAP46 PCNT ATP5F1C	4.34e-08	1442	147	23	35575683
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RPL21 PPAN CASP14 ACLY ABCF2 CHD3 CHD4 BTAF1 IDH3B SRCAP DDX10 CCT6A SMC3 KIF14 SNRNP200 TOP2B PCNT ATP5F1C	3.64e-07	1024	147	18	24711643
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RPL21 NEBL ACLY DHX38 GPATCH4 CHD3 CHD4 BTAF1 SRCAP TTC1 DDX10 PSME3IP1 DHX29 SNRNP200 TOP2B PRRC2B PCNT	4.88e-07	934	147	17	33916271
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	CCZ1B STUB1 FIS1 SRCAP TTC1 PLEKHG5 CCZ1 AASS RPEL1 RPE CRAMP1 PCNT	6.22e-07	457	147	12	32968282
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL21 PPAN KMT2B DHX38 ABCF2 EVPL GPATCH4 CHD3 CHD4 IFI16 LUZP1 ZNF462 CCT6A SMC3 SNRNP200 TOP2B	6.67e-07	847	147	16	35850772
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	RPL21 STUB1 DTNA ACLY CAPN2 FN3KRP ABCF2 EVPL PSMD10 LUZP1 SNX6 SMC3 CCT6B DHX29 SNRNP200 CLUH PRRC2B	8.68e-07	974	147	17	28675297
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABR KMT2B TRIO BTAF1 CLDN7 SRCAP ARHGEF11 NPHP4 PLEKHG5 SLC2A1 FAT1 TNRC18 ARHGAP44 KCNQ2 MICAL3 CRAMP1 PRRC2B PCNT	1.08e-06	1105	147	18	35748872
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RPL21 STUB1 SYNM DTNA SPTAN1 FASTKD5 TTC1 SLC2A1 DDX10 FAM171A1 NDUFAF1 SNX6 TMEM209 EFR3B SCFD1 MAP2K1 DHX29 SNRNP200 CLUH TOP2B PCNT	1.28e-06	1487	147	21	33957083
Pubmed	Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity.	CHD3 CHD4 PCNT	1.47e-06	6	147	3	17626165
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RPL21 ABR DTNA ACLY ABCF2 FAM171A1 CCT6A ARFGAP2 SMC3 EFR3B MICAL3 DHX29 SNRNP200 ATP5F1C	2.04e-06	708	147	14	39231216
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	RPL21 LPCAT1 STUB1 INTS7 EML4 ACLY SPTAN1 CAPN2 FN3KRP DHX38 ABCF2 GPATCH4 CHD4 IDH3B CCT6A SMC3 SNRNP200 CLUH TOP2B ATP5F1C	2.32e-06	1415	147	20	28515276
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	RPL21 ABR EML4 ACLY SPTAN1 ABCF2 GPATCH4 LUZP1 DDX10 SYNJ2 DHX29 CLUH TOP2B PRRC2B	2.64e-06	724	147	14	36232890
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	PPAN STUB1 SPTAN1 FASTKD5 ABCF2 CHD4 BTAF1 IDH3B IFI16 CCT6A AASS TMEM209 KIF14 MICAL3 SCFD1 DHX29 SNRNP200 TOP2B PRRC2B ATP5F1C	3.02e-06	1440	147	20	30833792
Pubmed	Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.	RPL21 INTS7 CILK1 ABCF2 DDX10 ZNF462 CCT6A LIMK1 TSBP1 PRRC2B ATP5F1C	4.82e-06	463	147	11	27503909
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	STUB1 SYNM FASTKD5 FIS1 GPATCH4 IDH3B TTC1 SLC2A1 ATL1 LUZP1 CCT6A NDUFAF1 SNX6 AASS TMEM209 SCFD1 CLUH PRRC2B PCNT ATP5F1C	5.33e-06	1496	147	20	32877691
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KMT2B SYNM SRCAP ARHGEF11 SYNJ2 RIMS1	5.55e-06	104	147	6	9205841
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	RPL21 THSD7A TRIO INTS7 SPTAN1 WASHC1 PHKB SERPINE2 DHX29 TOP2B PRRC2B	6.14e-06	475	147	11	31040226
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RPL21 CCZ1B STUB1 ACLY FN3KRP FASTKD5 ABCF2 PSMD10 BTAF1 IDH3B CCT6A SMC3 CCZ1 AASS TMEM209 CCT6B SNRNP200 ATP5F1C	6.51e-06	1257	147	18	37317656
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	RPL21 ACLY SPTAN1 IDH3B SLC2A1 CCT6A SMC3 TMEM209 SCFD1 TOP2B ATP5F1C	7.33e-06	484	147	11	31995728
Pubmed	Human transcription factor protein interaction networks.	PPAN KMT2B CASP14 STUB1 ATXN7L1 DTNA SPTAN1 GPATCH4 CHD3 SRCAP DDX10 ZNF462 CCT6A FAT1 SMC3 WDCP ZNF746 PRRC2B ATP5F1C	1.01e-05	1429	147	19	35140242
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RPL21 LPCAT1 ABCF2 GPATCH4 CHD4 IDH3B IFI16 LUZP1 CCT6A SNRNP200 TOP2B ATP5F1C	1.03e-05	601	147	12	33658012
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RPL21 PPAN CASP14 DHX38 GPATCH4 CHD3 CHD4 DDX10 SMC3 SNRNP200 TOP2B ATP5F1C	1.10e-05	605	147	12	28977666
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	SPTAN1 CAPN2 EVPL LUZP1 KIF14 PCNT	1.15e-05	118	147	6	30979931
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL21 PPAN ACLY DHX38 FASTKD5 ABCF2 GPATCH4 CHD4 SLC2A1 DDX10 PLEK2 CCT6A SMC3 SCFD1 MAP2K1 SNRNP200 TOP2B ATP5F1C	1.23e-05	1318	147	18	30463901
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	SLC25A18 SASH1 ACLY SPTAN1 CAPN2 FIS1 SLC2A1 ATL1 CCT6A CCT6B MAP2K1 ATP5F1C	1.42e-05	621	147	12	22794259
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	RPL21 SPTAN1 ABCF2 CHD3 CHD4 SRCAP SLC2A1 CCT6A SNX6 SMC3 DHX29 SNRNP200 PCNT ATP5F1C	1.56e-05	847	147	14	35235311
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	1.77e-05	2	147	2	7560064
Pubmed	The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.	NPR1 NPR2	1.77e-05	2	147	2	30696704
Pubmed	Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP.	NPR1 NPR2	1.77e-05	2	147	2	17848634
Pubmed	Role of efficient neurotransmitter release in barrel map development.	ADCY1 RIMS1	1.77e-05	2	147	2	16525048
Pubmed	An essential role for the Glut1 PDZ-binding motif in growth factor regulation of Glut1 degradation and trafficking.	GIPC1 SLC2A1	1.77e-05	2	147	2	19016655
Pubmed	Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB.	NPR1 NPR2	1.77e-05	2	147	2	23186809
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	1.77e-05	2	147	2	7575689
Pubmed	Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.	NPR1 NPR2	1.77e-05	2	147	2	20977274
Pubmed	Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.	ACLY SLC2A1	1.77e-05	2	147	2	25837797
Pubmed	ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.	NPR1 NPR2	1.77e-05	2	147	2	21828054
Pubmed	Porcine natriuretic peptide type B (pNPPB) maintains mouse oocyte meiotic arrest via natriuretic peptide receptor 2 (NPR2) in cumulus cells.	NPR1 NPR2	1.77e-05	2	147	2	24615855
Pubmed	Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB.	NPR1 NPR2	1.77e-05	2	147	2	24699414
Pubmed	Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.	NPR1 NPR2	1.77e-05	2	147	2	22133375
Pubmed	Cleavage and activation of LIM kinase 1 as a novel mechanism for calpain 2-mediated regulation of nuclear dynamics.	CAPN2 LIMK1	1.77e-05	2	147	2	34381117
Pubmed	CB1 receptors down-regulate a cAMP/Epac2/PLC pathway to silence the nerve terminals of cerebellar granule cells.	RAPGEF4 RIMS1	1.77e-05	2	147	2	28445587
Pubmed	Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.	NPR1 NPR2	1.77e-05	2	147	2	22949736
Pubmed	Enhanced expression of natriuretic peptide receptor A and B in neutrophils of culprit lesions in patients with acute myocardial infarction.	NPR1 NPR2	1.77e-05	2	147	2	28765884
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	1.77e-05	2	147	2	35568926
Pubmed	ATP-independent activation of natriuretic peptide receptors.	NPR1 NPR2	1.77e-05	2	147	2	15911610
Pubmed	The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.	NPR1 NPR2	1.77e-05	2	147	2	21366551
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	1.77e-05	2	147	2	8843877
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ABR TRIO ATXN7L1 DTNA DAB1 CILK1 CHD3 BTAF1 ADCY1 ZNF462 PHKB TNRC18 SYNJ2 ARHGAP44 MICAL3 RIMS1 BAIAP3 CRAMP1 PCNT	1.79e-05	1489	147	19	28611215
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	RPL21 EML4 ACLY SPTAN1 CHD4 IDH3B CCT6A SMC3 SCFD1 SNRNP200 TOP2B ATP5F1C	1.85e-05	638	147	12	33239621
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	CCZ1B CHD4 IFI16 CCT6A SMC3 TOP2B	1.91e-05	129	147	6	23022380
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	THSD7A ATXN7L1 ARHGEF11 SYNJ2 SNRNP200 CLUH	1.99e-05	130	147	6	12421765
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPL21 ANKRD35 PPAN NEBL STUB1 ACLY SPTAN1 ABCF2 GPATCH4 CHD4 IDH3B LUZP1 CCT6A TNRC18 SMC3 MAP2K1 ATP5F1C	2.24e-05	1247	147	17	27684187
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SYNM ACLY SPTAN1 EVPL BTAF1 LUZP1 CCT6A MICAL3 PCNT	2.43e-05	360	147	9	33111431
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL21 PPAN SYNM ACLY SPTAN1 DHX38 ABCF2 EVPL IFI16 SLC2A1 LUZP1 PLEK2 CCT6A SMC3 KIF14 SNRNP200 ATP5F1C	2.48e-05	1257	147	17	36526897
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	PPAN STUB1 INTS7 CAPN2 GPATCH4 PHKB AASS WDCP TOP2B	2.64e-05	364	147	9	24778252
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	NEBL TRIO ACLY SPTAN1 CAPN2 PSMD10 SLC2A1 ATL1 SERPINE2 RIMS1 ATP5F1C	2.73e-05	558	147	11	35063084
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	STUB1 ACLY CHD3 BTAF1 IDH3B LUZP1 PCNT ATP5F1C	3.07e-05	285	147	8	32838362
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	RPL21 GIPC1 STUB1 ACLY SPTAN1 CHD4 PSMD10 TTC1 LUZP1 PHKB CCT6A SNX6 SMC3 MICAL3 SCFD1 SNRNP200	3.08e-05	1149	147	16	35446349
Pubmed	Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.	CHD3 CHD4 PCNT	3.24e-05	15	147	3	9804427
Pubmed	Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches.	RPL21 PPAN ABCF2 CHD4 SMC3 SNRNP200	3.69e-05	145	147	6	27049334
Pubmed	Defining the membrane proteome of NK cells.	RPL21 GIPC1 LPCAT1 ABR EML4 ACLY DHX38 ABCF2 FIS1 CHD4 IFI16 LUZP1 SLC44A1 KIF14 PCNT ATP5F1C	3.74e-05	1168	147	16	19946888
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	RPL21 DHX38 CHD4 SRCAP CCT6A WDCP CCT6B SNRNP200	4.41e-05	300	147	8	28561026
Pubmed	Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series.	ACLY IDH3B PHKB RPEL1 RPE	4.86e-05	93	147	5	27215380
Pubmed	Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin.	SYNM DTNA	5.31e-05	3	147	2	11353857
Pubmed	PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.	CCZ1B CCZ1	5.31e-05	3	147	2	32160108
Pubmed	A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A.	NPR1 NPR2	5.31e-05	3	147	2	16430226
Pubmed	Skeletal muscle derived Musclin protects the heart during pathological overload.	NPR1 NPR2	5.31e-05	3	147	2	35013221
Pubmed	Regulation of natriuretic peptides postprandially in vivo and of their receptors in adipocytes by fatty acids in vitro.	NPR1 NPR2	5.31e-05	3	147	2	29409758
Pubmed	Human umbilical cord mesenchymal stem cell-derived exosomal miR-214-3p regulates the progression of gallbladder cancer by regulating ACLY/GLUT1.	ACLY SLC2A1	5.31e-05	3	147	2	37747441
Pubmed	Tissue-specific subunit of the mouse cytosolic chaperonin-containing TCP-1.	CCT6A CCT6B	5.31e-05	3	147	2	9013858
Pubmed	Pancreatic cancer-derived exosomal microRNA-19a induces β-cell dysfunction by targeting ADCY1 and EPAC2.	RAPGEF4 ADCY1	5.31e-05	3	147	2	34512170
Pubmed	Chromosomal distribution of three members of the human natriuretic peptide receptor/guanylyl cyclase gene family.	NPR1 NPR2	5.31e-05	3	147	2	1979052
Pubmed	Biochemical genetics of the pentose phosphate cycle: human ribose 5-phosphate isomerase (RPI) and ribulose 5-phosphate 3-epimerase (RPE).	RPEL1 RPE	5.31e-05	3	147	2	7396409
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4	5.31e-05	3	147	2	32658897
Pubmed	Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.	NPR1 NPR2	5.31e-05	3	147	2	25117468
Pubmed	Retinal degeneration protein 3 controls membrane guanylate cyclase activities in brain tissue.	NPR1 NPR2	5.31e-05	3	147	2	36618828
Pubmed	Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize.	NPR1 NPR2	5.31e-05	3	147	2	15459247
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPL21 SLC25A18 ACLY SPTAN1 ABCF2 GPATCH4 CHD4 IFI16 LUZP1 DDX10 CCT6A SMC3 SNRNP200 ATP5F1C	5.36e-05	949	147	14	36574265
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KMT2B KMT5A GPATCH4 CHD3 CHD4 BTAF1 SRCAP DDX10 ZNF462 SMC3 TOP2B	5.91e-05	608	147	11	36089195
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	RPL21 STUB1 CHDH SPTAN1 ABCF2 SNRNP200 TOP2B	6.03e-05	231	147	7	36597993
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	RPL21 KMT2B SPTAN1 CHD4 SRCAP LUZP1 DDX10 CCT6A CCT6B SNRNP200	6.25e-05	506	147	10	30890647
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GIPC1 ABR TRIO SPTAN1 RAPGEF4 CHD4 ARHGEF11 LUZP1 ZNF462 FAM171A1 ARHGAP44 RIMS1 PRRC2B PCNT	6.26e-05	963	147	14	28671696
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	PPAN ACLY SPTAN1 DHX38 GPATCH4 IFI16 DDX10 CCT6A	6.35e-05	316	147	8	31665637
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SASH1 PLEKHG5 SV2B BAIAP3 SNRNP200	7.20e-05	101	147	5	9872452
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SASH1 TRIO GRK7 SPTAN1 DNAH7 LUZP1 FAM171A1 ARFGAP2 LIMK1 SYNJ2 AASS KIF14 MAP2K1	7.93e-05	861	147	13	36931259
Pubmed	Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma.	GIPC1 EVPL BTAF1 IFI16 CCT6A DHX29 SNRNP200 PRRC2B	8.40e-05	329	147	8	34316702
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	ABCF2 GPATCH4 CHD3 CHD4 DDX10 KIF14 SNRNP200 TOP2B	8.58e-05	330	147	8	33301849
Pubmed	Mass spectrometry analyses of normal and polyglutamine expanded ataxin-3 reveal novel interaction partners involved in mitochondrial function.	LPCAT1 STUB1 ACLY IDH3B	8.84e-05	55	147	4	29111377
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TRIO SPTAN1 CAPN2 CHD3 CHD4 FAT1 TNRC18 PRRC2B	8.95e-05	332	147	8	37433992
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	RPL21 ABR SPTAN1 IDH3B PHKB CCT6A FAT1 SLC2A12 SNRNP200 CCDC33 ATP5F1C	9.18e-05	639	147	11	23443559
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	RPL21 CASP14 STUB1 ACLY SPTAN1 ABCF2 CHD3 CCT6A SNRNP200 TOP2B ATP5F1C	9.44e-05	641	147	11	36057605
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RPL21 TRIO DTNA SPTAN1 CAPN2 ATL1 CCT6A ARFGAP2 TNRC18 SERPINE2 KCNQ2 AK1 RIMS1 DHX29 FKBP2	1.02e-04	1139	147	15	36417873
Pubmed	Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.	STUB1 LIMK1	1.06e-04	4	147	2	17512523
Pubmed	Characterization of the CHD family of proteins.	CHD3 CHD4	1.06e-04	4	147	2	9326634
Pubmed	Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis.	GIPC1 PLEKHG5	1.06e-04	4	147	2	21543326
Interaction	RHOB interactions	GIPC1 LPCAT1 ABR TRIO DTNA SPTAN1 FASTKD5 ARHGEF11 SLC2A1 FAM171A1 CCT6A FAT1 SNX6 TMEM209 EFR3B KIF14 MICAL3 SCFD1 MAP2K1 TOP2B	2.30e-06	840	144	20	int:RHOB
Interaction	ACTB interactions	NEBL STUB1 DTNA ACLY SPTAN1 WASHC1 DAB1 CHD3 CHD4 PSMD10 SRCAP IFI16 NPHP4 LUZP1 CCT6A ARFGAP2 SMC3 KIF14 LMOD1 FGD5 TOP2B ATP5F1C	8.89e-06	1083	144	22	int:ACTB
Interaction	KCTD13 interactions	RPL21 TRIO ACLY SPTAN1 CAPN2 RAPGEF4 CHD3 IDH3B ARHGEF11 PLEKHG5 SLC2A1 LUZP1 PHKB CCT6A SLC44A1 SV2B ARHGAP44 KCNQ2 MICAL3 RIMS1 MAP2K1 DHX29 SNRNP200 PRRC2B ATP5F1C	1.74e-05	1394	144	25	int:KCTD13
Interaction	PWP2 interactions	ABCF2 GPATCH4 CHD3 CHD4 IFI16 SMC3 ZNF746 KIF14	3.36e-05	172	144	8	int:PWP2
Interaction	RPGRIP1L interactions	IDH3B NPHP4 LUZP1 SMC3 WDCP KIF14 CLUH FKBP14 PCNT	3.54e-05	225	144	9	int:RPGRIP1L
Interaction	COIL interactions	STUB1 DHX38 FASTKD5 GPATCH4 CHD3 CHD4 IFI16 SLC2A1 ZNF462 SNX6 KIF14 SNRNP200 TOP2B ATP5F1C	4.28e-05	552	144	14	int:COIL
Interaction	SIRT6 interactions	PPAN STUB1 ACLY DHX38 ABCF2 CHD3 CHD4 SRCAP FAT1 SMC3 WDCP TMEM209 DHX29 SNRNP200 TOP2B	4.48e-05	628	144	15	int:SIRT6
Interaction	RPL10A interactions	RPL21 STUB1 KMT5A CAPN2 ABCF2 GPATCH4 CHD3 CHD4 IFI16 DDX10 PIK3R6 ZNF746 KIF14	5.15e-05	490	144	13	int:RPL10A
Interaction	HSP90AB1 interactions	STUB1 DTNA GRK7 SPTAN1 KHDRBS2 CILK1 CHD3 NPHP4 SLC2A1 ARFGAP2 TNRC18 AASS ZNF746 KIF14 NEIL3 FGD5 MYO15A MAP2K1 ATP5F1C	5.50e-05	960	144	19	int:HSP90AB1
Interaction	TUBA1B interactions	EML4 KLHL40 CAPN2 CHD3 CHD4 IFI16 NPHP4 CCT6A SMC3 CCT6B KIF14 FGD5 SNRNP200	6.07e-05	498	144	13	int:TUBA1B
GeneFamily	EF-hand domain containing	LPCAT1 SPTAN1 CAPN2 EFHB DNAH7 CAPN11 FKBP14	2.28e-04	219	101	7	863
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	STUB1 FIS1 ODAD4 TTC1 CFAP46	4.65e-04	115	101	5	769
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR TRIO ARHGEF11 FGD5	5.07e-04	66	101	4	722
GeneFamily	Guanylate cyclase receptors	NPR1 NPR2	6.37e-04	7	101	2	343
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR BAIAP3 CCDC33	1.06e-03	36	101	3	823
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	1.97e-03	12	101	2	1305
GeneFamily	C2 domain containing\|Calpains	CAPN2 CAPN11	3.09e-03	15	101	2	975
GeneFamily	Chaperonins	CCT6A CCT6B	3.09e-03	15	101	2	587
GeneFamily	DEAH-box helicases	DHX38 DHX29	3.52e-03	16	101	2	500
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASHC1 WASH2P	3.52e-03	16	101	2	14
GeneFamily	LIM domain containing	NEBL LIMK1 MICAL3	4.39e-03	59	101	3	1218
GeneFamily	FKBP prolyl isomerases	FKBP2 FKBP14	4.46e-03	18	101	2	910
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_1000	THSD7A NEBL SYNM DAB1 ADCY1 SLC2A12	2.02e-05	85	139	6	gudmap_developingKidney_e15.5_Podocyte cells_1000_k2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DPYS DTNA CHDH KHDRBS2 FAM135B ZNF462 FAT1 MICAL3	2.00e-07	186	147	8	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	DPYS NEBL CHDH KHDRBS2 ZNF462 FAT1 SERPINE2	2.68e-06	184	147	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	droplet-Spleen-nan-3m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 DAPL1 EML4 RAPGEF4 CHD3 PIK3IP1 TOP2B	2.88e-06	186	147	7	26f1e9930adf2fe4af0819e56f69915bd8330e4a
ToppCell	droplet-Spleen-nan-3m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 DAPL1 EML4 RAPGEF4 CHD3 PIK3IP1 TOP2B	2.99e-06	187	147	7	91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 DAPL1 EML4 RAPGEF4 CHD3 PIK3IP1 TOP2B	2.99e-06	187	147	7	382db691eb0b3e089e816bed3d6699cc2d4e1bda
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO SPTAN1 RAPGEF4 IFI16 PLEKHG5 FAM171A1 PCNT	4.65e-06	200	147	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC25A18 SASH1 DTNA DNAH7 SLC22A6 SERPINE2 SLC2A12	4.65e-06	200	147	7	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 PLEKHG5 FAM171A1	4.65e-06	200	147	7	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC25A18 SASH1 DTNA DNAH7 SLC22A6 SERPINE2 SLC2A12	4.65e-06	200	147	7	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 LUZP1 FAM171A1	4.65e-06	200	147	7	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Healthy_donor-CD8+_T_naive\|Healthy_donor / disease group, cell group and cell class (v2)	RPL21 NEBL PIK3IP1 LRRN3 KCNQ2 TRAV24	2.10e-05	169	147	6	66216758e581365f10c2a66714d83a606ad23af0
ToppCell	CV-Healthy-4\|Healthy / Virus stimulation, Condition and Cluster	TRIO SLC2A1 SERPINE2 PIK3R6 SYNJ2 MAP2K1	2.47e-05	174	147	6	26544cc5f51cb4dc1251e62d9f80b6c956194d38
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DTNA DAB1 CCZ1 KCNQ2 CLUH CRAMP1	2.99e-05	180	147	6	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NEBL DTNA SPTAN1 KHDRBS2 CLDN7 EFHB	3.18e-05	182	147	6	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAPL1 EML4 CHD3 CHD4 CCT6A TOP2B	3.18e-05	182	147	6	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAPL1 EML4 CHD3 CHD4 CCT6A TOP2B	3.18e-05	182	147	6	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LPCAT1 NEBL CAPN2 KHDRBS2 EVPL ARHGAP44	3.28e-05	183	147	6	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPAN EML4 CHDH GPATCH4 DDX10 CCT6A	3.28e-05	183	147	6	92ef926e6c1de8477fa4f35d1dae85482d8009de
ToppCell	droplet-Marrow-nan-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPAN EML4 CHDH GPATCH4 DDX10 CCT6A	3.28e-05	183	147	6	24db9cc717e651586317c6a8e03a3401651273c1
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	THSD7A NEBL DTNA KHDRBS2 ARHGAP44 EFR3B	3.38e-05	184	147	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTNA DAB1 ATL1 SGCZ LMOD1 RIMS1	3.48e-05	185	147	6	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ODAD4 EFHB DNAH7 BAIAP3 CFAP46 CCDC33	3.48e-05	185	147	6	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SLC25A18 SYNM DTNA LMOD1 FGD5 RIMS1	3.59e-05	186	147	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	DPYS DTNA CHDH KHDRBS2 FAT1 SERPINE2	3.70e-05	187	147	6	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GIPC1 NEBL CAPN2 KHDRBS2 ARHGAP44 EFR3B	3.70e-05	187	147	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A NEBL PLEK2 EFR3B LMOD1 FGD5	3.81e-05	188	147	6	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	THSD7A RAPGEF4 FAM171A1 SERPINE2 SYNJ2 FGD5	3.81e-05	188	147	6	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPAN CHDH GPATCH4 PIK3IP1 PHKB CCT6A	3.81e-05	188	147	6	e079a3873cf442e98ff41a240c80b80995aace11
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A SASH1 WNT9B RAPGEF4 SV2B FGD5	3.93e-05	189	147	6	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR173 NPHP4 ZNF462 ARHGAP44 LMOD1 RIMS1	3.93e-05	189	147	6	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DPYS DTNA CHDH KHDRBS2 FAM135B FAT1	3.93e-05	189	147	6	28b502611829e4a24caff2562545c7db97686099
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR173 NPHP4 ZNF462 ARHGAP44 LMOD1 RIMS1	3.93e-05	189	147	6	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	THSD7A NEBL CAPN2 KHDRBS2 ARHGAP44 EFR3B	3.93e-05	189	147	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 THSD7A RAPGEF4 SERPINE2 EFR3B FGD5	4.04e-05	190	147	6	cb8798839c27f307955fcc94a1ee40bca95b8e99
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	THSD7A SYNM RAPGEF4 SV2B MICAL3 FGD5	4.04e-05	190	147	6	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 THSD7A RAPGEF4 SERPINE2 EFR3B FGD5	4.04e-05	190	147	6	5bf3d0beee69879c95265d07fba023626a7cc808
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 NEBL TRIO DNAH7 ZNF462 FAT1	4.16e-05	191	147	6	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO DTNA FAM135B ZNF462 FAT1 MICAL3	4.16e-05	191	147	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A SASH1 RAPGEF4 SV2B FCN2 FGD5	4.16e-05	191	147	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABR IFI16 SERPINE2 SYNJ2 EFR3B FGD5	4.29e-05	192	147	6	56b021c297a21dff357531f21e2464f85186106d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD7A SASH1 RAPGEF4 FAM171A1 PIK3R6 FGD5	4.41e-05	193	147	6	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD7A SASH1 RAPGEF4 FAM171A1 PIK3R6 FGD5	4.41e-05	193	147	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD7A SASH1 RAPGEF4 FAM171A1 PIK3R6 FGD5	4.41e-05	193	147	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A NEBL DTNA KHDRBS2 ARHGAP44 EFR3B	4.67e-05	195	147	6	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABR THSD7A RAPGEF4 FAM171A1 SERPINE2 FGD5	4.67e-05	195	147	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	THSD7A EML4 CHD3 BTAF1 AK1 SNRNP200	4.95e-05	197	147	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABR RAPGEF4 IFI16 SERPINE2 SYNJ2 FGD5	5.09e-05	198	147	6	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM RAPGEF4 FAM171A1 SV2B MICAL3 FGD5	5.09e-05	198	147	6	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM RAPGEF4 FAM171A1 SV2B MICAL3 FGD5	5.09e-05	198	147	6	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	metastatic_Brain-Epithelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	LPCAT1 CAPN2 FIS1 CLDN7 CCT6A AK1	5.23e-05	199	147	6	5c0cd611dbf2014e0ae6ce9fe8b619ceb4006e43
ToppCell	metastatic_Brain-Epithelial_cells-Malignant_cells\|metastatic_Brain / Location, Cell class and cell subclass	LPCAT1 CAPN2 FIS1 CLDN7 CCT6A AK1	5.23e-05	199	147	6	56df2b342c77b33299cfb407e1e05f42940f2946
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ODAD4 EFHB DNAH7 BAIAP3 CFAP46 CCDC33	5.38e-05	200	147	6	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SLC25A18 ABR NEBL DTNA DNAH7 EFR3B	5.38e-05	200	147	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ODAD4 EFHB DNAH7 BAIAP3 CFAP46 CCDC33	5.38e-05	200	147	6	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 RAPGEF4 IFI16 FAM171A1	5.38e-05	200	147	6	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	041a34080120c9f613373c20dcc366292f558040
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC25A18 DTNA DNAH7 SLC22A6 SERPINE2 SLC2A12	5.38e-05	200	147	6	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 SPTAN1 RAPGEF4 IFI16 PLEKHG5 FAM171A1	5.38e-05	200	147	6	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron\|3m / Sample Type, Dataset, Time_group, and Cell type.	RPL21 THSD7A SPTAN1 DAB1 CHD3 ADCY1	5.38e-05	200	147	6	c248233b004f8ef0bab3c65ecfe295887966f2ee
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal\|3m / Sample Type, Dataset, Time_group, and Cell type.	RPL21 THSD7A SPTAN1 CHD3 ADCY1 ZNF462	5.38e-05	200	147	6	af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FGD5	5.38e-05	200	147	6	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 SPTAN1 RAPGEF4 IFI16 PLEKHG5 FAM171A1	5.38e-05	200	147	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 SASH1 SPTAN1 IFI16 LUZP1 FAM171A1	5.38e-05	200	147	6	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_D3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF11 DDX10 SERPINE2 RPEL1 KCNQ2	1.41e-04	150	147	5	580ed7733857402345f43ca2623f72cdd1edf22c
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ODAD4 EFHB DNAH7 CFAP46 CCDC33	1.59e-04	154	147	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ODAD4 EFHB DNAH7 CFAP46 CCDC33	1.59e-04	154	147	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ODAD4 EFHB DNAH7 CFAP46 CCDC33	1.64e-04	155	147	5	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ODAD4 EFHB DNAH7 CFAP46 CCDC33	1.64e-04	155	147	5	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR173 DAB1 WDCP LMOD1 RIMS1	1.74e-04	157	147	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS7 FN3KRP KIF14 NEIL3 BAIAP3	1.79e-04	158	147	5	ee8ce3cd202807df692b28bb1a81827d49d73862
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM169 ABCA12 DTNA SGCZ AASS	1.90e-04	160	147	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM169 ABCA12 DTNA SGCZ AASS	1.90e-04	160	147	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Control-Classical_Monocyte-cMono_1\|Classical_Monocyte / Disease condition and Cell class	RPL21 WASHC1 ZNF302 ADA2 ATP5F1C	2.01e-04	162	147	5	b44021f4750e9ff3ac7f683ef8255dd2087f2c05
ToppCell	normal-na-Lymphocytic_T-T4_reg-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	THSD7A NEBL CHDH CHD3 PIK3IP1	2.07e-04	163	147	5	43887e7687fc6367efac0c1f56a9534b06f47b7f
ToppCell	Mild-Myeloid-Mast\|Mild / Condition, Lineage, Cell class and cell subclass	THSD7A EVPL FAM135B ZNF462 PIK3R6	2.19e-04	165	147	5	5fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCell	Mild-Myeloid-Mast-\|Mild / Condition, Lineage, Cell class and cell subclass	THSD7A EVPL FAM135B ZNF462 PIK3R6	2.19e-04	165	147	5	93d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCell	COVID-CD8-exh_CD4\|COVID / Condition, Cell_class and T cell subcluster	LPCAT1 ACLY LRRN3 SERPINE2 SYNJ2	2.25e-04	166	147	5	4ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_AIM2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A SASH1 ABCA12 IFI16 SGCZ	2.32e-04	167	147	5	4c8bb68ee2bf7b794940b34df96f38f3f69507e9
ToppCell	facs-Skin-Anagen-24m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD35 CLCA4 CASP14 ABCA12 EVPL	2.32e-04	167	147	5	02c89069dcd0e87f7502e32b14e7cbd3cab81a09
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_1\|Classical_Monocyte / Disease condition and Cell class	DAB1 ADA2 FCN2 WDCP ATP5F1C	2.38e-04	168	147	5	d50078614f7af74dc2aa4081c1708a5156ac51cf
ToppCell	Int-URO-Lymphocyte-T_NK-CD4_Naive\|Int-URO / Disease, Lineage and Cell Type	RPL21 WNT9B PIK3IP1 USP44 LRRN3	2.52e-04	170	147	5	577915dd1f5c418b9b98a7a7153e2b5d1b93ca84
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A SASH1 ABCA12 IFI16 ZNF462	2.73e-04	173	147	5	2e35bf2b5534a289d93a09faae660f665c131062
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_1\|Classical_Monocyte / Disease condition and Cell class	ABCF2 ADA2 PLEKHG5 FCN2 ATP5F1C	2.88e-04	175	147	5	35ea2ed93538e6bf803029fcf7d9243f93e7733d
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 RAPGEF4 CLDN7 ADCY1 RIMS1	2.88e-04	175	147	5	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR DAB1 EVPL CLDN7 PLEK2	2.88e-04	175	147	5	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	THSD7A SASH1 RAPGEF4 FAM171A1 SV2B	2.95e-04	176	147	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	THSD7A SASH1 RAPGEF4 FAM171A1 SV2B	2.95e-04	176	147	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; HL60; HT_HG-U133A	GIPC1 DTNA SPTAN1 ABCF2 CHD3 SRCAP ARHGEF11 SERPINE2 SYNJ2	4.91e-06	198	144	9	1853_DN
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A	KMT2B SASH1 TRIO CILK1 ABCF2 SRCAP ARHGEF11 SYNJ2 WDCP	5.11e-06	199	144	9	7436_DN
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	STUB1 EML4 DTNA CAPN2 CAPN11	7.76e-07	36	141	5	DOID:11723 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1L (implicated_via_orthology)	SGCD SGCZ	6.78e-05	3	141	2	DOID:0110436 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	TRIO SRCAP SMC3 KCNQ2 RIMS1	8.60e-05	93	141	5	C1535926
Disease	complement factor H-like 1 protein measurement	THSD7A SYNJ2 KCNQ2	1.54e-04	22	141	3	EFO_0600092
Disease	hereditary spastic paraplegia 76 (implicated_via_orthology)	CAPN2 CAPN11	2.25e-04	5	141	2	DOID:0110821 (implicated_via_orthology)
Disease	Child Development Disorders, Specific	CHD4 SLC2A1 KCNQ2	3.56e-04	29	141	3	C0085997
Disease	Child Development Deviations	CHD4 SLC2A1 KCNQ2	3.56e-04	29	141	3	C0085996
Disease	Developmental Disabilities	CHD4 SLC2A1 KCNQ2	3.95e-04	30	141	3	C0008073
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN2 ATL1 CAPN11	1.15e-03	43	141	3	DOID:2476 (implicated_via_orthology)
Disease	Congenital ichthyosis of skin	CASP14 ABCA12	1.21e-03	11	141	2	cv:C0020758
Disease	rotator cuff tear	THSD7A SASH1	1.45e-03	12	141	2	EFO_1001250
Disease	Retinitis Pigmentosa	CCZ1B DHX38 IDH3B SNRNP200	1.59e-03	104	141	4	C0035334
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	CCZ1B CCZ1	1.99e-03	14	141	2	DOID:3753 (implicated_via_orthology)
Disease	interleukin 12 measurement	CAPN11 ZNF462 SERPINE2	2.10e-03	53	141	3	EFO_0004753
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B TRIO	2.94e-03	17	141	2	DOID:0060307 (is_implicated_in)
Disease	Myeloid Leukemia	SMC3 TOP2B	3.30e-03	18	141	2	C0023470
Disease	Leukemia, Monocytic, Chronic	SMC3 TOP2B	3.30e-03	18	141	2	C0023466
Disease	Cardiomyopathies	NEBL SGCD DTNA MAP2K1	3.56e-03	130	141	4	C0878544
Disease	Disorder of eye	IDH3B NPHP4 USH1G RIMS1 SNRNP200	3.58e-03	212	141	5	C0015397
Disease	unipolar depression, mood disorder	THSD7A ARFGAP2 LMOD1 CLUH	3.97e-03	134	141	4	EFO_0003761, EFO_0004247
Disease	maximal midexpiratory flow rate	SGCD MICAL3	4.07e-03	20	141	2	EFO_0004313
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	CCT6A CCT6B	4.49e-03	21	141	2	DOID:0060036 (implicated_via_orthology)
Disease	muscular dystrophy (implicated_via_orthology)	SGCD SGCZ	4.49e-03	21	141	2	DOID:9884 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
MQKKLERRKQGGEGT	USH1G	216	Q495M9
MLVSGAGDIKLTKDG	CCT6A	46	P40227
GKGLEMRKLVLSGFL	ABR	86	Q12979
KGDGVILKDLMKTAG	AHSA2P	126	Q719I0
GIGKSMLLSAIGKRE	ABCF2	121	Q9UG63
KMLTGKGLDGLHVER	CCDC33	526	Q8N5R6
CRKLNEVIGLKGMGR	BAIAP3	306	O94812
GGMKRKLSISIALIG	ABCA12	1481	Q86UK0
AAKMLLDGEIGAKGL	AASS	881	Q9UDR5
GAAMKAGVKEGDRII	ARHGEF11	76	O15085
KILKMNGETGRDLDG	CFAP46	1581	Q8IYW2
KVDMDKLLGGQIGLE	GIPC1	106	O14908
EGKKREQAERLGMGL	ARFGAP2	296	Q8N6H7
QLELRGDVEMKGKGK	NPR2	1016	P20594
GGLAKGQLEKEMSVL	ANKRD35	606	Q8N283
ELELRGDVEMKGKGK	NPR1	1031	P16066
LMDKDGSGKLGLLEF	CAPN11	621	Q9UMQ6
DKGMISGRLTAKKLQ	DHX29	111	Q7Z478
KAGGMRISKKQEIGT	DAPL1	21	A0PJW8
EAGKEGGKSREVMRL	ATXN7L1	66	Q9ULK2
MLSGIGNADDLKKLG	CHDH	306	Q8NE62
KGDLGMLKKLVEDGV	ANKRD42	246	Q8N9B4
MDGGSLDQVLKKAGR	MAP2K1	146	Q02750
LMELDKGLRSGKLGE	INTS7	26	Q9NVH2
MKGQEGAASKVLGRL	SLC2A12	226	Q8TD20
EKVISVRLMAKDAGG	FAT1	2561	Q14517
GLKGMCVGEKRKLII	FKBP14	91	Q9NWM8
VGLGMKILLDSGLEK	KIF14	1421	Q15058
SERARMKGGEKIGIA	LPCAT1	356	Q8NF37
QLLTEKALMELGGGK	FAM171A1	686	Q5VUB5
EKALRGEAGMGKKDD	MICAL3	1876	Q7RTP6
EEGMKIDLIDGKGRG	KMT5A	256	Q9NQR1
ESEVKKQKGRMLGDV	NEIL3	166	Q8TAT5
QGLLGMCEGEKRKLV	FKBP2	91	P26885
KKLTGRLMLAVGGAV	SLC2A1	6	P11166
KLGEMRLKEAGTVGR	FN3KRP	116	Q9HA64
GIKLLRMVKGGQEAG	MYO15A	2796	Q9UKN7
VIKQKDGTVEMRGKD	IHO1	426	Q8IYA8
SARGKKLSEIMEKGQ	AK1	51	P00568
GDLIAEGAKKMLALG	DPYS	196	Q14117
EKMGVLEEGGKGKEA	GPATCH4	301	Q5T3I0
ERLIDKAMKKDGLVG	FIS1	111	Q9Y3D6
GRLGKVEKQVLSMEK	KCNQ2	621	O43526
DTRKEGEKMKRAGGN	LMOD1	231	P29536
DLEIKTKIRMSGIKG	EFR3B	156	Q9Y2G0
KLQEMAGKRSGVEKE	EVPL	1216	Q92817
GREFLKEGTLMKVTG	FGD5	1111	Q6ZNL6
VLGMLQLGADGRTKK	SERPINE2	61	P07093
VIGGKGSDRKCLNKM	KLHL40	466	Q2TBA0
DRRAGGQMKGLLLKL	KMT2B	1486	Q9UMN6
VRMNSKEKKDLGTLG	PIK3IP1	156	Q96FE7
MRLSLEDGGKGKEKV	PCNT	2041	O95613
IMLAAGEGKGVNKRI	NPHP4	1336	O75161
LGLKVVGGKMTDLGR	RIMS1	616	Q86UR5
KTVLRIKGEGDMAKA	OR56A5	226	P0C7T3
VCRGKVSVKGKGEML	ADCY1	1036	Q08828
GLMEAGESELKRKVK	CD1E	196	P15812
VKKKMRGDGDLDLNG	CHFR	256	Q96EP1
TDDLMNKLLKGKARG	FASTKD5	626	Q7L8L6
KVIKVGKVRTRDMGG	IDH3B	351	O43837
EESVKLFRGVKKMGG	ATL1	396	Q8WXF7
MKLKGVVAGARSKGE	DAB1	66	O75553
MLLEVKARAKEKTGG	BTAF1	626	O14981
KMVGLEGSDKLTILR	FCN2	36	Q15485
KTRIQTLKKGLGEDM	SLC25A18	246	Q9H1K4
EGGALIKSSGKLMLL	CHD3	1051	Q12873
MKGKEEKEGGARLGA	STUB1	1	Q9UNE7
MEDGGVKLLKERLEK	CCZ1	156	P86791
DKTIGGRSEVFLKMG	NDUFAF1	141	Q9Y375
GELRKKIGGCMDDKN	CRAMP1	251	Q96RY5
EGELKIAMDGLRKKQ	DNAH7	2821	Q8WXX0
MEDGGVKLLKERLEK	CCZ1B	156	P86790
GIGGMKADLRTLKQL	ADA2	461	Q9NZK5
VDKDVKKIMGGSGTE	LUZP1	761	Q86V48
RLLGMDEVKGEKQLG	GPR173	271	Q9NS66
LMEEKFRGDAGLGKL	IFI16	51	Q16666
LEGLMKLLKTQGAGS	DTNA	546	Q9Y4J8
GKDDLGDKRVIMGTK	EFHB	11	Q8N7U6
LQEETGAKMSILGKG	KHDRBS2	91	Q5VWX1
ILGKGSMRDKAKEEE	KHDRBS2	101	Q5VWX1
KEVMLVGIGDKIRGI	ATP5F1C	126	P36542
VENSRKAMKEAGKGG	SLC44A1	626	Q8WWI5
GMLLTGGGKDRKIIL	EML4	521	Q9HC35
MSILQKGGKRLEGTE	DDX10	556	Q13206
KNGKESLKVGLARME	CCDC168	2576	Q8NDH2
STLGKGIDQEGKMVL	FAM135B	616	Q49AJ0
RLSDLGLAVEMKGGK	GRK7	331	Q8WTQ7
REGFLKGEDGEMVKL	CASP14	91	P31944
VDMLDSDGSGKLGLK	CAPN2	581	P17655
ELMRGEEGRPGKKLK	CHD4	676	Q14839
GKREEGAKLSMEVLR	SLC22A6	296	Q4U2R8
DMLAALKKGIIGGVK	PHKB	636	Q93100
VAKGGLGLILKRMVE	PSMD10	211	O75832
LGGKDELTMAVRKEL	RUNDC1	416	Q96C34
DKLGSGEGLIIVKMS	RAPGEF4	701	Q8WZA2
MLVSGAGDIKLTKDG	CCT6B	46	Q92526
GKATLVMKKGDVEGS	SMC3	1051	Q9UQE7
DVLAGMSGKAIKGKV	TOP2B	1206	Q02880
GGLADKLGRKRVLSM	SV2B	166	Q7L1I2
EGKVEVLLGMKVQGD	THSD7A	976	Q9UPZ6
GLKGKSAEQMIGDII	SYNM	716	O15061
LSVLDVDGMKVKGRA	SYNJ2	946	O15056
LVGADLKSVMIKVDG	LRRN3	501	Q9H3W5
LDEDLIKGTMKGGLT	ODAD4	206	Q96NG3
IKGTMKGGLTVEDLI	ODAD4	211	Q96NG3
MDGGDDGNLIIKKRF	PSME3IP1	1	Q9GZU8
MERAGLQRKGGIKKR	PIK3R6	361	Q5UE93
ERGEIEVKGKGRMTT	GUCY1B2	546	O75343
DGMGNLRVTKKGIRL	SGCZ	66	Q96LD1
KDMSVVEGGLRARKL	SKIV2L	991	Q15477
KLNGILADEMGLGKT	SRCAP	636	Q6ZRS2
GDDTLLGKMLKLCGE	ARHGAP44	86	Q17R89
EGKLIMGIGHRVKSI	ACLY	966	P53396
DKVKKARIAMGGGII	CLDN7	111	O95471
GRSIESGELIAIKKM	CILK1	21	Q9UPZ9
LDKSGSMGGKDRLNR	CLCA4	311	Q14CN2
DLGDSGKRKKGLEMD	CLUH	166	O75153
MEEKGSKRGLEAAGK	TNRC18	946	O15417
LLEGSLRMKEGKDSK	PLEKHG5	586	O94827
MEDGVLKEGFLVKRG	PLEK2	1	Q9NYT0
VMTLNGDEKKKGRIS	TRAV24	71	A0A0B4J272
KDIRENGMKVGLAIK	RPEL1	106	Q2QD12
KSLEGMKKARVGGSD	PPAN	346	Q9NQ55
MGNLRITEKGLKLEG	SGCD	66	Q92629
LLELGEKRKGMLEKS	SPTAN1	1076	Q13813
QAGGIGKAKLRSMKE	WASH2P	371	Q6VEQ5
QAGGIGKAKLRSMKE	WASHC1	371	A8K0Z3
MSDRLGQITKGKDGK	PRRC2B	1	Q5JSZ5
KGDIVDIKGMGTVQK	RPL21	36	P46778
RSLTEGEMKKGLGSL	SASH1	386	O94885
KRLKSIMGLEGEDEG	SCFD1	356	Q8WVM8
AGTKLGDIMGVKKEE	DHX38	471	Q92620
GEKTLIEKMFGGKLR	USP38	581	Q8NB14
KLQKLGEGEGSMTKE	SNX6	106	Q9UNH7
KTKESGMLGRVNLGL	TMEM209	536	Q96SK2
LSLVGKLEGTRMGDK	SNRNP200	41	O75643
LMGSDGNKLLETKGI	ZNF462	416	Q96JM2
RLLSLEGRTGMAEKK	ZNF746	31	Q6NUN9
SLEGRMGLLKRGFKE	WNT9B	101	O14905
MELGKGKLLRTGLNA	WDCP	1	Q9H6R7
KDIRENGMKVGLAIK	RPE	106	Q96AT9
GTITRGKKKGQMVDI	TMEM169	106	Q96HH4
REGKGTDLEKDKIGM	TSBP1	276	Q5SRN2
ERLKEEMLGKLKDLG	TTC1	241	Q99614
LSGGASKGRKMELIQ	USP44	356	Q9H0E7
GKGEIKDGLEVMLSV	TRIO	1446	O75962
LMILLKGGEQKGHDK	TRAV30	66	A0A087WSZ9
RLGIKMGKQGIINKE	ZNF302	151	Q9NR11
IKGGTLRGIIKSMDS	LIMK1	416	P53667
KDLESIIKGKGMQAG	NEBL	451	O76041
IIKGKGMQAGTDTLE	NEBL	456	O76041